Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers

被引：0
|
作者：
Lee, Jaeyop [1 ]
Ku, Geoffrey [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 03期
关键词：
HER2; Esophagogastric cancer; Trastuzumab; Antibody drug conjugate; Immune modulation; Immunotherapy; Targeted therapy; ANTIBODY-DRUG CONJUGATE; GASTROESOPHAGEAL JUNCTION CANCER; GASTRIC-CANCER; TRASTUZUMAB DERUXTECAN; ADVANCED BREAST; HER2; STATUS; SINGLE-ARM; OPEN-LABEL; LAPATINIB; COMBINATION;
D O I：
10.1016/j.hoc.2024.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：585 / 598
页数：14
相关论文
共 50 条
  • [41] Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1 (vol 6, pg 537, 1999)
    Kern, JA
    Akita, RW
    Sliwkowski, MX
    CANCER GENE THERAPY, 2000, 7 (02) : 166 - 166
  • [42] Epidermal growth factor receptor-targeted therapy for pancreatic cancer
    Xiong, HQ
    Abbruzzese, JL
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 31 - 37
  • [43] Development of epidermal growth factor receptor targeted therapy in pancreatic cancer
    Qing, Liu
    Qing, Wang
    MINERVA CHIRURGICA, 2018, 73 (05) : 488 - 496
  • [44] Temozolomide and targeted therapy against epidermal growth factor receptor in glioma
    Daianu, Oana
    Georgescu, Ada Maria
    Ciurea, Marius Eugen
    Alexandru, Oana
    Artene, Stefan-Alexandru
    Tataranu, Ligia Gabriela
    Purcaru, Oana Stefana
    Tache, Daniela Elise
    Danciulescu, Maria-Mihaela
    Taisescu, Oana
    Folcuti, Roxana
    Dricu, Anica
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 15249 - 15261
  • [45] Epidermal growth factor receptor-targeted therapy in colorectal cancer
    O'Dwyer, PJ
    Benson, AB
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 10 - 17
  • [46] Epidermal growth factor receptor-targeted therapy for pancreatic cancer
    Papageorgio, Chris
    Perry, Michael C.
    CANCER INVESTIGATION, 2007, 25 (07) : 647 - 657
  • [47] Epidermal growth factor receptor-targeted therapy in colorectal cancer
    Xu, WeiDong
    Jing, HuaYong
    Zhang, FuLi
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 410 - 418
  • [48] Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab
    Zhang, Liyi
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (04) : 349 - 351
  • [49] Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis
    Hedner, Charlotta
    Tran, Lena
    Borg, David
    Nodin, Bjorn
    Jirstrom, Karin
    Eberhard, Jakob
    HISTOPATHOLOGY, 2016, 68 (02) : 230 - 240
  • [50] Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer
    Cho, Dong Hui
    Lee, Se Kyung
    Kim, Sangmin
    Choi, Min-Young
    Jung, Seung Pil
    Lee, Jeonghui
    Kim, Jiyoung
    Koo, Min Young
    Bae, Soo Youn
    Kim, Jung-Han
    Kim, Jee Soo
    Ho, Kil Won
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 84 (05): : 273 - 280
12345